Community/Retail

Women with a history of depression may have greater odds of developing gestational diabetes.

A new cardiovascular risk estimator can accurately predict heart disease and stroke risk for anyone in the world aged 40 years or older.

The bill will improve access to health care through pharmacists and their patient care services.

GlaxoSmithKline has voluntarily recalled all remaining FluLaval Quadrivalent Thimerosal-Free prefilled flu vaccine syringes.

By mentally rehearsing resuscitation procedures, trauma care team members can reduce clinical errors and improve patient safety.

NCPA supports this legislation in the hope that it can help achieve a better balance to reduce prescription drug abuse while ensuring those patients with chronic, debilitating pain have access to essential medications.

H.R. 471 will help curb prescription drug abuse and protect patient access to medically-necessary medications.

GRX Marketing co-founder Nicolle McClure describes how the company has continued to succeed in helping pharmacies thrive.

Anyssa Garza, PharmD, director of the Life Sciences Library at RxWiki, retuns to the Pharmacy Podcast Show for another "Common Misconceptions in Pharmacy" series.

Proposal substantially undervalues Perrigo and is not in the best interests of its shareholders.

Prescription opioid dispensing and overdoses decreased after abuse-deterrent oxycodone hit the market and propoxyphene left it.

Elizabeth Rodriguez, University of Colorado Skaggs School of Pharmacy student, gives her impressions of the American Pharmacists Association annual meeting.

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about how have value-based payment trends incentivize adherence.

Amit Gupta, RPh, a consultant pharmacist for Pharma-Care, talks about his experience attending Directions in Pharmacy's 5th annual CE Conference in March 2015.

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about the most successful tactics pharmacists can use to improve adherence.

Joseph Saseen, PharmD, FASHP, FCCP, FNLA, BCPS, CLS, professor in the Departments of Clinical Pharmacy and Family Medicine at University of Colorado Skaggs School of Pharmacy, talks about how pharmacy schools can prepare students for changes to the pharmacy industry.

The FDA has granted Orphan Drug Designation to AstraZeneca's selumetinib.

While pharmacists spend the majority of their time concentrating on patients' well-being, a video from University of Alberta pharmacy students serves as a reminder for peers to look after their own mental health.

Orphan drugs and breakthrough therapies last year comprised the highest number of new medications approved since 2001.

The Virginia State Board of Pharmacy shut down the prescription operations of a pharmacy in Richmond after deeming it deficient in several areas upon inspection.

A pharmacy professor is using her unique skin condition to teach students about drug molecules.

The NACDS Community Pharmacy-Based Point-of-Care Testing certificate program kicked off at the University of Nebraska Medical Center College of Pharmacy.

Deaths related to oxycodone overdose dropped 25% in Florida after the state adopted a Prescription Drug Monitoring Program to track controlled substance dispensing.

Abiraterone acetate (Zytiga) significantly prolongs survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about how medication adherence is measured.

Elizabeth Rodriguez, University of Colorado Skaggs School of Pharmacy student, talks about what the most important issue facing pharmacists.

Joseph Saseen, PharmD, FASHP, FCCP, FNLA, BCPS, CLS, professor in the Departments of Clinical Pharmacy and Family Medicine at University of Colorado Skaggs School of Pharmacy, talks about how the role of the pharmacist is evolving.

While the FDA only recommends daily aspirin for patients who have experienced major cardiovascular events, about half of older adults in the United States take aspirin regularly.

The companies will collaborate on a Phase 1 study to evaluate the safety and efficacy of birinapant, TetraLogic's SMAC-mimetic, in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with relapsed or refractory solid tumors.